Pre-Cancerous Dysplasia: Clinical Trials

2 recruiting, 1 completed. 2 Phase 2, 1 Not applicable.

By phase and status

Phase	Trials	Status
Phase 2	2	Recruiting 2
Not applicable	1	Completed 1

Follow Pre-Cancerous Dysplasia: new trials by email Literature Review of Pre-Cancerous Dysplasia trials Research Report on Pre-Cancerous Dysplasia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) Artesunate ointment, Placebo ointment - Vulvar Diseases, HPV Infection	Phase 2	Recruiting	Frantz Viral Therapeutics, LLC	27	2023-12-06	2025-08-14
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) Artesunate vaginal insert, Placebo vaginal insert - CIN 2/3, HPV Infection	Phase 2	Recruiting	Frantz Viral Therapeutics, LLC	78	2020-09-09	2025-10-02
Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge) Self-collected HPV testing for cervical cancer screening - Human Papillomavirus 16, Human Papillomavirus 18	Not applicable	Completed	University of British Columbia	2019	2019-08-01	2022-11-03

Narrower conditions

Papillomavirus Infections (3)  ·  Uterine Cervical Dysplasia (1)  ·  Uterine Cervical Neoplasms (1)  ·  Vulvar Diseases (1)

Broader conditions

Communicable Diseases (3)  ·  DNA Virus Infections (3)  ·  Disease Attributes (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Infections (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Sexually Transmitted Diseases (3)  ·  Sexually Transmitted Diseases, Viral (3)  ·  Tumor Virus Infections (3)  ·  Urogenital Diseases (3)  ·  Virus Diseases (3)

Interventions

artemisinin (2)  ·  artesunic acid (2)  ·  artenimol (1)

Sponsors

Frantz Viral Therapeutics, LLC (2)  ·  University of British Columbia (1)

Countries

United States (2)  ·  Uganda (1)

Top investigators

Carolyn Nakisige, MD (1)  ·  Gina Ogilvie, MD (1)  ·  Sheona Mitchell-Foster, MD (1)

Results publications

PMID 32005202, PMID 35384556, PMID 36408923, PMID 37037880, PMID 39681893